MapLight Therapeutics MPLT
NASDAQ MPLT
$7.48 +0.04 (+0.54%)
At close: Nov 11, 2026 · 4:00 PM EST

MapLight Therapeutics (MPLT) Consolidated Net Income (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) recorded Consolidated Net Income of -$61.2 million in Q2 2026, compared with -$29.98 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) Consolidated Net Income (2024 - 2026) Analysis & Trends

On a TTM basis, MapLight Therapeutics' Consolidated Net Income came in at -$202.03 million as of Jun 30, 2026; for FY2025, it was -$163.57 million.

  • Across earlier years, Consolidated Net Income came in at -$78.44 million in FY2024.
  • Quarterly Consolidated Net Income has ranged from -$80.91 million in Q4 2025 to -$19.81 million in Q3 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 210.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.12 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 2.43 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.25 Bn
10 MapLight Therapeutics 338.05 Mn 33.33 Mn - -60.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -60.25 Mn
Mar 31, 2026 -61.32 Mn
Dec 31, 2025 -79.82 Mn
Sep 30, 2025 -29.42 Mn
Jun 30, 2025 -29.88 Mn
Mar 31, 2025 -22.42 Mn
Dec 31, 2024 -21.49 Mn
Sep 30, 2024 -18.40 Mn
API Access

MapLight Therapeutics Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=MPLT&period=max&api_key=YOUR_API_KEY